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Thiazolidinedione (TZD), a specific peroxisome proliferator-activated receptor γ (PPARγ) 
agonist, was developed to control blood glucose in diabetes patients. However, several 
side effects were reported that increased the risk of heart failure. We used C2C12 myo-
blasts to investigate the role of PPARs and their transcriptional activity during myotube 
formation. The role of mechanical stretch during myogenesis was also explored by 
applying cyclic stretch to the differentiating C2C12 myoblasts with 10% strain defor-
mation at 1  Hz. The myogenesis medium (MM), composed of Dulbecco’s modified 
Eagle’s medium with 2% horse serum, facilitated myotube formation with increased 
myosin heavy chain and α-smooth muscle actin (α-SMA) protein expression. The PPARγ 
protein and PPAR response element (PPRE) promoter activity decreased during MM 
induction. Cyclic stretch further facilitated the myogenesis in MM with increased α-SMA 
and decreased PPARγ protein expression and inhibited PPRE promoter activity. Adding 
a PPARγ agonist (TZD) to the MM stopped the myogenesis and restored the PPRE 
promoter activity, whereas a PPARγ antagonist (GW9662) significantly increased the 
myotube number and length. During the myogenesis induction, application of cyclic 
stretch rescued the inhibitory effects of TZD. These results provide novel perspectives 
for mechanical stretch to interplay and rescue the dysfunction of myogenesis with the 
involvement of PPARγ and its target drugs.
Keywords: myogenesis, PPar, stretch, c2c12, myotube formation
Abbreviations: α-SMA, α-smooth muscle actin; DM, diabetes mellitus; DMEM, Dulbecco’s modified Eagle’s medium; ERK, 
extracellular signal-regulated kinase; GM, growth medium; JNK, c-Jun N-terminal kinase; MAPK, mitogen-activated protein 
kinase; MHC, myosin heavy chain; MM, myogenesis medium; PPAR, peroxisome proliferator-activated receptor; PPRE, PPAR 
response element; RSG, rosiglitazone; SF, serum-free DMEM; TZD, thiazolidinedione.
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inTrODUcTiOn
Muscle tissue is packed with an ordered array of myofibers com-
posed of tightly bundled, long, cylindrical multinucleated muscle 
cells. The repeated actin–myosin myofibrils are the contractile 
units of the muscle filaments that slide during contraction. The 
effect of mechanical stimulation on cell homeostasis and devel-
opment, which are critical factors in tissue maintenance, repair, 
and regeneration, has drawn a lot of attention (Su et al., 2011). In 
myogenesis, the constant mechanical and chemical stimulations 
drive the myogenic cells to become stable postmitotic multinucle-
ated muscle (Pownall et al., 2002). Mechanical stretch can alter the 
organization of stress fibers in myocytes (Yamazaki et al., 1996; 
Hornberger et al., 2005; Saygili et al., 2007), smooth muscle cells 
(Simpson et al., 1994), and endothelial cells (Kaunas et al., 2005). 
Skeletal muscle has the ability to restore its cellular architecture 
after injury; however, myogenesis involves a complex sequence of 
molecular events that is particularly relevant to human diseases, 
such as inherited myopathies, systemic metabolic diseases, and 
common cardiovascular disorders (Bassel-Duby and Olson, 2006).
Type 2 diabetes mellitus (DM), accounting for approximately 
90% of the diabetic population, is a metabolic disorder caused 
by insulin resistance. Thiazolidinedione (TZD) and rosiglitazone 
(RSG) are insulin sensitizers and are used as second-line drugs if 
the first-line drug – metformin – fails to control DM. Peroxisome 
proliferator-activated receptors (PPARs) are a group of ligand-
dependent nuclear receptors with three isoforms: PPARα, PPARδ, 
and PPARγ. The different PPARs form a complex with cofactors 
to regulate their downstream target genes with diverse functions 
in different tissues (Rosen and MacDougald, 2006). TZD drugs 
work as PPARγ agonists to bind its receptors in fat cells and ren-
der the cells more responsive to insulin in DM patients. Although 
TZD-related drugs showed promising results in maintaining 
blood sugar levels, an increased incidence of heart disease and 
death has been reported in patients prescribed RSG (Steven and 
Nissen, 2007; Chen et al., 2012). A safety alert for RSG had been 
released by the U.S. Food and Drug Administration regarding 
its side effects with respect to cardiovascular risk (Graham et al., 
2010; Komajda et al., 2010). Cautions for prescribing and admin-
istering TZD or RSG have been suggested, although the pros and 
cons of using these drugs are not yet conclusive (Kaul et al., 2010).
Exercise and dietary habits help to manage the initial stage 
of DM (Raina Elley and Kenealy, 2008). To study mechani-
cal responses in cultured cells, the cells are maintained on the 
extracellular matrix-coated elastic membrane, which is then 
stretched to observe the cellular responses (Su et  al., 2011). 
Application of cyclic stretching (1  Hz) to mouse preadipocyte 
3T3-L1 cells inhibited adipocyte differentiation through extracel-
lular signal-regulated kinase (ERK)-mediated downregulation of 
PPARγ2 (Tanabe et al., 2004). Cyclic stretching (10% at 0.5 Hz) 
also induced transforming growth factor β1-Smad signaling to 
inhibit adipogenic markers in human umbilical cord perivas-
cular cells (Turner et  al., 2008). C2C12 cells, a mouse-derived 
myoblast cell line (Yaffe and Saxel, 1977; Blau et al., 1985), is an 
ideal in  vitro model for studying the molecular basis of myo-
genesis. Mechanical stretch activates rapamycin and adenosine 
monophosphate-activated protein kinase signaling (Nakai et al., 
2015), phosphorylates Src-mediated myogenesis (Niu et  al., 
2013), and inhibits Toll-like receptor 3 autoantigens associated 
with inflammatory myopathy in C2C12 myoblasts (Chen et al., 
2013). The in vitro ectopic expression of PPARγ in C2C12 cells 
induced their transdifferentiation into adipocytes (Hu et  al., 
1995). However, the influence of PPARs and their transcriptional 
activity when subjecting C2C12 myoblasts to mechanical stretch 
remains unknown. Furthermore, understanding the effect of RSG 
treatment on myogenesis dysfunction and intracellular PPARγ 
signaling during stretch might provide a comprehensive overview 
of drug usage to facilitate prevention of side effects in early DM. 
The current study investigated the role of PPARs and their tran-
scriptional activity during different responses of myogenesis to 
stretch and/or RSG treatments. We discovered that cyclic stretch 
promoted myogenesis by decreasing the PPARγ protein expres-
sion and promoter activity that could prohibit the inhibitory 
effects of PPARγ agonist drugs.
MaTerials anD MeThODs
cell culture and Differentiation
Mouse C2C12 myoblasts were purchased from the American 
Type Culture Collection (ATCC, VA, USA) and routinely 
cultured in Dulbecco’s modified Eagle’s medium (DMEM) 
(Invitrogen, Carlsbad, CA, USA) with 10% fetal bovine 
serum (Hyclone, Logan, UT, USA) at 37°C and 5% CO2. The 
undifferentiated myoblasts were maintained in subconfluent 
conditions to avoid differentiation. To evaluate the response of 
myogenesis and myotube formation to biochemical factors, the 
C2C12 cells (3 × 105 cells) were seeded on 6-cm culture dishes 
coated with type I collagen (BD Biosciences, Franklin Lakes, 
NJ, USA), rinsed twice with phosphate-buffered saline (PBS) 
after cells reached monolayer confluency, and then replenished 
with fresh growth medium (GM), serum-free (SF) DMEM, 
or myogenesis medium (MM, DMEM containing 2% horse 
serum). Myotube formation was evaluated on phase-contrast 
microscopy (Olympus) images acquired at different time points. 
The myotube number per square centimeter and the average 
length of myotubes were quantified using ImageJ software to 
indicate the efficiency of myogenesis. Length of myotube were 
carefully measured by drawing line along the long axis of myo-
tube between two myotube tips and convert the pixels into the 
unit of length in ImageJ software.
Mechanical stretch
A stretch system (STREX Cell Stretching system, ST-190; B-Bridge 
International, Inc., Cupertino, CA, USA) was used to apply cyclic 
uniaxial stretch with the deformation of 10% and frequency at 
1 Hz (10%, 1 Hz). The C2C12 cells (2 × 105 cells) were seeded 
in  silicon stretch chambers coated with type I collagen. The 
C2C12 cells reached 90–100% confluency after being cultured in 
regular GM for 24 h. The cells were then rinsed with PBS, replen-
ished with GM or MM, and incubated for an additional 24 h to 
initiate myogenesis induced by biochemical factors. The role of 
mechanical factors in myogenesis was tested by subjecting these 
cells to cyclic stretch for 1 h and then collecting the cell lysates.
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PPar Drug Treatments and luciferase 
reporter assays
The TZD, RSG, CAY10599, GW9662, WY14643, MK886, and 
MG132 reagents were purchased from Cayman Chemical (Ann 
Arbor, MI, USA). All reagents were dissolved in ethanol, except 
GW9662, which was dissolved in dimethyl sulfoxide for the stock 
solution and then diluted 1:10 in ethanol to achieve a concentra-
tion of 1 μM. To measure the PPAR promoter activity, we used a 
PPAR response element (PPRE) reporter conjugated to luciferase 
kindly provided by Drs. K. W. Kinzler and B. Vogelstein (Johns 
Hopkins University, Baltimore, MD, USA) (Liou et  al., 2008). 
The C2C12 cells were transfected with the PPRE constructs using 
Lipofectamine 2000 (Invitrogen) for 24 h, washed with PBS, and 
then replenished with the medium containing the relevant drug. 
For measuring PPRE transcriptional activity during cyclic stretch, 
transfected C2C12 cells were transferred to the stretch chamber 
for  24  h and incubated for an additional 24  h with a different 
medium. PPRE activity was measured by collecting cells after they 
were subjected to cyclic stretch for 1  h. Luciferase activity was 
measured in cell lysates using the firefly luciferase kit (Promega, 
Madison, WI, USA) and a Sirius luminometer (Berthold Detection 
System; Berthold Technologies, Bad Wildbad, Germany) to 
measure the emitted light. The transcriptional activity of PPRE 
was quantified as relative light units per microgram of protein and 
expressed as fold change normalized to a control group.
Western Blotting
The C2C12 myoblasts were treated with different biochemical 
and/or mechanical stimuli for specific times. Protein expression 
was assessed by collecting the cell lysates after rinsing cells twice 
with cold PBS and lysing with RIPA buffer containing protease 
inhibitors (Liu and Brooks, 2012). Briefly, cell lysate supernatants 
containing 30 μg total protein were transferred to nitrocellulose 
membranes (Bio-Rad, Hercules, CA, USA) following SDS-PAGE 
on 10% cross-linked gels. The membranes were blocked by 5% 
dry milk in Tris-buffered saline with 0.1% Tween 20 for 90 min. 
Antibodies for phospho-ERK1/2 (1:2000 dilution; Cell Signaling 
Technology, Danvers, MA, USA), ERK (1:1000; Santa Cruz 
Biotechnology, Santa Cruz, CA, USA), phospho-c-Jun N-terminal 
kinase (JNK) (1:1000; Cell Signaling Technology), JNK (1:1000; 
Santa Cruz Biotechnology), phospho-Akt (1:1000; Cell Signaling 
Technology), Akt (1:1000; Santa Cruz Biotechnology), myosin 
heavy chain (MHC) (1:4000; Sigma-Aldrich, St. Louis, MO, 
USA), α-smooth muscle actin (α-SMA) (1:4000; Sigma-Aldrich), 
PPARα (1:1000; Thermo Fisher Scientific, Waltham, MA, USA), 
PPARδ (1:1000; Cayman Chemical), PPARγ (1:500; Cell Signaling 
Technology), and β-actin (1:10000; Sigma) were incubated at 4°C 
overnight for evaluation of protein expression levels. The bound 
primary antibodies were detected using appropriate second-
ary antibodies coupled to horseradish peroxidase (Santa Cruz 
Biotechnology) and an enhanced chemiluminescence detection 
system (Pierce Biotechnology, Rockford, IL, USA).
Immunofluorescence Staining
To investigate the protein expression of myogenic markers, we 
used immunofluorescence staining to determine the myogenesis 
in C2C12 during different medium treatments. Briefly, cells 
were rinsed with PBS twice and fixed by 4% paraformaldehyde 
(Sigma-Aldrich) after various treatments. Then, the 0.1% Triton 
X-100 was used for cell membrane permeabilization prior the 
overnight hybridization of primary antibodies. The MHC and 
α-SMA were the same antibodies used in Western Blotting 
for indicating myogenesis. The FITC-conjugated secondary 
antibodies were used to visualize the myotube structure. The 
rhodamine phalloidin was used to indicate the cytoskeleton 
structure for stress fiber in all undifferentiated and differentiated 
C2C12 cells. Cell nucleus was identified with 4, 6-diamidino-
2-phenylindole (DAPI) staining.
statistical analysis
All experiments were repeated at least three times, and the data 
are expressed as means ± SDs. Statistical analysis was performed 
using one-way analysis of variance and the Scheffé post hoc test. 
Values of p < 0.05 were considered statistically significant.
resUlTs
Myogenesis Decreased PParγ Protein 
and Transcriptional activity
After the C2C12 myoblasts reached monolayer confluency, the 
switch to SF for 72 h not only induced some myotube forma-
tion but also caused cell death (rounding up and floating) 
(Figure 1A, SF). The MM significantly induced cell fusion into 
myotubes and increased the number of myotubes (Figure 1A). 
Successful myogenesis was confirmed by an increase in MHC 
and α-SMA protein expression after culturing C2C12 in MM 
for 72  h (Figure  1B). Immunofluorescence staining further 
demonstrated the myotube structures in myogenesis-specific 
markers, especially for the strip pattern of MHC staining, after 
MM induction for 72  h (Figure  1C, green color). The multi-
nucleus structure after cell fusion to form the myotube can 
also be visualized by DAPI staining (Figure  1C, blue color). 
The intracellular stress fiber (Figure 1C, red color) was stained 
to indicate the cytoskeleton of all C2C12 cells. To investigate 
the role of PPARs in myogenesis, their protein expression was 
assessed, and a decrease in PPARγ was observed in C2C12 cells 
treated with SF or MM (Figure  2A). The protein expression 
of PPARα and PPARδ did not change after replacement with 
different culture medium. The PPRE promoter activity showed 
continuous decreases after switching to MM for 24, 48, and 72 h 
(Figure 2B). These results suggested the involvement of PPARγ 
and its transcriptional activity during biochemical-induced 
myogenesis. The confluent C2C12 cells cultured in MM had 
decreased PPAR transcriptional activity leading to a reduction 
of PPARγ protein.
cyclic stretch enhanced Myogenesis 
and Facilitated suppression of PParγ 
expression
Since the mechanical stimulation induced myogenic dif-
ferentiation, we were interested to examine how cyclic 
stretch interacted with biochemical factors to influence the 
FigUre 2 | PParγ protein expression was decreased during 
myogenesis (a). The transcriptional activity of PPARs was decreased as 
measured by the promoter luciferase reporter construct of the PPAR-
responsive element (PPRE) (B). *Significant difference compared with GM 
(p < 0.05).
FigUre 1 | Monolayers of c2c12 myoblasts were switched to growth medium (gM), serum-free medium (sF), or myogenic medium (MM) for 5 days, 
and myotube formation was then quantified (a). Induction of myogenesis was confirmed by the increase in myogenic protein markers myosin heavy chain 
(MHC) and α-smooth muscle actin (α-SMA) (B). The confluency of C2C12 cells was demonstrated by immunofluorescence staining of cytoskeleton (red color for 
stress fiber) and nucleus (blue color for DAPI) in both GM and MM (c). The mature myotube structure was visualized using MHC (green color, left panel) and the 
expression of early myogenesis marker was indicated by α-SMA (green color, right panel) after MM induction for 5 days. The striation of mature myotube was 
observed by MHC staining (zoom-in image). *Significant difference compared with GM (p < 0.05). Scale bar for (a): 200 μm. Scale bar for (c): 50 μm.
4
Chang et al. Stretch Rescues TZD-Inhibited Myotube Formation
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org March 2016 | Volume 4 | Article 27
intracellular signals and PPAR expression during myogenesis. 
The application of cyclic stretch for 1 h facilitated myogenesis 
as indicated by increasing α-SMA expression in MM but not 
in GM (Figure  3A). The stretch induced different mitogen-
activated protein kinase (MAPK) signals in GM and MM. In 
regular GM, the cyclic stretch increased the phosphorylation 
of ERK (p-ERK). The C2C12 cells in MM also showed minor 
ERK phosphorylation, but the major MAPK signal triggered by 
stretch was JNK phosphorylation. The expression level of PPARγ 
protein was slightly decreased in GM, but almost abolished 
when applying stretch in MM (Figure 3B). The cyclic stretch 
also decreased the PPRE promoter activity in MM (Figure 3C). 
These data indicate the common inhibition of PPARγ during 
myogenesis by both biochemical and mechanical stimulation. 
Under biomechanical induction, the mechanical stretch further 
promotes myogenesis.
FigUre 3 | application of cyclic stretch (10% strain at 1 hz for 1 h) in 
MM with further induced myogenesis as indicated by increased 
α-sMa expression (a). The phosphorylation of JNK was induced by 
applying stretch in MM, whereas ERK phosphorylation was observed when 
stretch was applied in GM. A decrease in PPARγ protein expression was also 
found during stretch-induced myogenesis in MM (B). The number below 
each lane indicates the quantified fold change with normalized to GM static 
condition and its individual β-actin. A further decrease of PPRE promoter 
activity was detected when applying cyclic stretch (c). *Significant difference 
compared with GM (p < 0.05). #Significant difference compared with MM 
under static conditions (p < 0.05).
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PParγ agonist inhibited Myogenesis 
and Myotube Formation
The effects of TZD on myogenesis were then assessed by treat-
ing C2C12 cells with 10 μM TZD in GM or MM. Since TZD is 
a PPARγ agonist, the opposite effect of decreasing PPARγ was 
also tested by adding GW9662 (1 μM), a PPARγ antagonist. 
After 72-h culture, the phase images were taken randomly 
at five areas in each treatment and measured the number 
and length of myotube using ImageJ software. In MM, TZD 
significantly inhibited myotube formation, whereas GW9662 
increased the number and length of myotubes (Figure  4A). 
The inhibition of myogenesis by a PPARγ agonist was also 
observed with administration of RSG, another member of the 
TZD class of drugs (Figure S1 in Supplementary Material). 
The effects of PPARγ agonists and antagonists in myogenesis 
were confirmed by decreasing and increasing MHC protein 
expression, respectively (Figure 4B). However, altering PPARγ 
signaling in biochemical-induced myogenesis using TZD or 
GW9662 did not change the α-SMA expression levels. The 
PPRE promoter assay showed that the reduction of transcrip-
tional activity in MM was reversed by adding TZD to the MM 
(Figure 4C). To assess whether other PPARs also play a role in 
the myogenic process, C2C12 cells were treated with a PPARα 
agonist (10 μM WY14643 or ciprofibrate) or antagonist (10 μM 
MK886) for monitoring the degree of myogenesis (Figure S2 in 
Supplementary Material). There were no significant differences 
in MHC expression after administration of the drugs related to 
PPARα signaling.
stretch Prevented the inhibitory effect of 
PParγ agonist on Myogenesis
Since cyclic stretch promoted myogenesis in MM, we further 
tested the interactions of mechanical stretch and TZD treat-
ments. The TZD was added to the MM after C2C12 cells were 
transferred to the stretch chamber for 24 h and then incubated 
for an additional 24  h. Compared with the stretch induction 
in MM, TZD treatment lowered α-SMA expression, and the 
application of stretch for 1  h under TZD treatment slightly 
prevented this inhibitory effect (Figure  5A). The prevention 
of TZD-reduced myogenesis was demonstrated by blocking 
PPRE promoter activity after the cyclic stretch (Figure  5B). 
Since mechanical stretch promoted myogenesis via a decrease 
in PPARγ, the proteasome inhibitor MG-132 was added to 
prevent ubiquitin-dependent protein degradation. Our results 
showed that MG-132 restored the decrease of PPARγ after 
stretch (Figure 5C). Consistent with our hypothesis that PPARγ 
activation would inhibit myogenesis, when cells were treated 
with TZD to evoke PPARγ expression, myogenesis was inhib-
ited, and the application of mechanical stretch rescued this side 
effect of TZD.
DiscUssiOn
In the current study, we used a simple myotube formation 
platform of C2C12 myoblasts to discover the role of PPARγ 
and its agonist in inhibiting myogenesis, which may explain 
in part the side effects of TZD administration. We found that 
the intracellular PPARγ levels were crucial in the progression 
of myogenesis. Lower PPARγ levels promoted myogenesis 
(Figure  1), whereas elevation of PPARγ levels inhibited cell 
differentiation (Figure  4). PPARα is found mainly expressed 
in tissues with a high metabolic rate, such as liver, muscle, 
kidney, and heart (Issemann and Green, 1990; Braissant et al., 
1996). The expression of PPARγ is abundant in the intestine 
and adipose tissue (Tontonoz et al., 1994; Mansén et al., 1996), 
whereas PPARδ is expressed ubiquitously (Braissant et  al., 
1996). When DM patients use the TZD class of drugs to sensitize 
insulin, the increase in PPARγ protein expression in myogenic 
cells reduces its benefits. The inhibition of myogenesis causes 
major problems in muscle homeostasis, which may manifest 
not only in skeletal but also in cardiac muscles. In striated 
muscles, both the skeletal and cardiac myocytes repeatedly 
encounter stretch stimulation. Their strategies to cope with 
these mechanical signals may be conserved in evolution. The 
administration of a PPARγ activator, such as TZD or RSG, may 
block the regenerative potential in muscle progenitor cells. For 
elderly patients who may be more prone to muscle injuries, the 
therapeutic strategies of using TZD drugs to treat DM may be 
FigUre 4 | The addition of TZD (PParγ agonist) abolished the MM-induced myotube formation, but gW9662 (gW, PParγ antagonist) increased the 
number and length of myotubes (a). The effect of PPARγ on myogenesis was confirmed by MHC protein expression, which was decreased with TZD and 
increased with GW treatment (B). The administration of TZD significantly increased PPRE promoter activity (c). *Significant difference compared with GM without 
drugs (Ct) (p < 0.05). #Significant difference compared with MM without drugs (Ct) (p < 0.05).
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harmful with respect to muscle regeneration. However, cardiac 
hypertrophy caused by mechanical overload can be inhibited by 
increasing the PPARγ levels with treatments of TZD drugs or 
15-deoxy-Δ12,14-prostaglandin J2 (Yamamoto et al., 2001; Yue Tl 
et al., 2001). Taken together with those of others in the literature, 
our findings allow us to highlight the importance of PPARγ in 
myogenesis. However, manipulation of PPARγ levels should be 
undertaken more carefully while considering the complexity of 
diseases when using TZD drugs.
Cells in skeletal muscle are constantly receiving mechanical 
and biochemical signals for developing highly differentiated 
muscle fibers. Stretch can enhance myogenesis and increase 
muscle mass (Goldspink et al., 1992) and, thus, is important in 
rehabilitation after muscle injury. In the hypothesis of mecha-
notransduction, the intracellular signal transduction initiates 
the mechanical signals that are transmitted from the extracel-
lular matrix through membrane receptors, such as integrin or 
anchorage points linking to the cytoskeleton (Chien, 2007). 
Not only the decreases in PPARγ and its transcriptional activity 
under cyclic stretch but also other intracellular signaling path-
ways are involved in stretch-induced myogenesis. In the current 
study, we found that JNK was phosphorylated when facilitating 
myogenesis using a combination of biochemical and mechani-
cal stimuli (Figure  3A). Uniaxial cyclical stretch can induce 
myoblast proliferation via a cyclooxygenase-2-dependent 
mechanism (Otis et  al., 2005). The upregulation of nuclear 
factor-κB transcriptional activity was also found during stretch-
induced myogenesis through the phosphorylation of p38 and 
RelA signaling (Ji et al., 2010). The addition of PPARγ ligands 
associated with IκB to inhibit nuclear factor-κB after mechanical 
stimulation (Tomita et al., 2005). The importance of PPARγ in 
muscle differentiation was also reported with the connection 
to MyoD (Solanes et al., 2003). These results suggested that the 
intracellular levels of PPARγ were important in the progression 
of myogenesis. C2C12 cells treated with PPARγ agonist showed 
inhibited myogenesis, whereas a decrease in PPARγ levels pro-
moted cell differentiation.
The stretch could enhance myosin expression and restore the 
retarded myogenesis caused by PPARγ activation. The PPRE 
promoter assay can detect the transcriptional activity of all 
different isoforms of PPARs (Liou et al., 2008). In the current 
study, there were no significant differences in the expression 
levels of PPARα and PPARδ. Therefore, the reduction of tran-
scriptional activity may result from the decrease of PPARγ pro-
tein expression and cause a feedback loop to negatively regulate 
its signaling. The increase of PPRE activity induced by adding 
TZD into the MM was abolished by cyclic stretch (Figure 5B). 
These findings suggested that the mechanical stretch may cause 
the dissociation of PPRE binding. Much evidence has shown 
that exercise, a type of mechanical stimulation, inhibits adipose 
tissue formation and increases muscle tissue mass (Tanabe 
et al., 2004).
FigUre 5 | after applying the cyclic stretch for 1 h, α-sMa protein 
expression was increased with TZD treatment in MM (a). The number 
below each lane indicates the quantified fold change with normalized to static 
condition without TZD and its individual β-actin. The mechanical stretch also 
inhibited the TZD-induced PPRE promoter activity (B). The decreased PPARγ 
protein expression can be reversed by adding the protease inhibitor MG-132 
during the cyclic stretch (c). *Significant difference compared with GM 
without drugs (p < 0.05).
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cOnclUsiOn
This study explored the effects of mechanical forces on the cellular 
effects of PPARγ-related signaling and may explain the mechani-
cal regulation of muscle mass on a microscopic scale. Therefore, 
the mechanical benefits of regulating PPARγ using cyclic stretch 
or exercise can be properly addressed in muscle homeostasis.
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